Budapest, Hungary

Peter Miskolczi

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Miskolczi. Retrieved from https://idiyas.com/inventor/peter-miskolczi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Miskolczi: Innovator in Pharmaceutical Chemistry

Introduction

Peter Miskolczi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug preparation. His work has led to advancements that benefit the medical community and enhance therapeutic options.

Latest Patents

Peter Miskolczi holds a patent for a process titled "Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine." This invention outlines a method for synthesizing a complex chemical compound, which is crucial for developing new medications. The patent represents his commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Peter has worked with Sanofi, a leading global healthcare company. His role at Sanofi has allowed him to collaborate with other talented professionals in the field. His dedication to innovation and research has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Peter Miskolczi has collaborated with esteemed colleagues such as Janos Fazekas and Annamaria Molnar. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical chemistry.

Conclusion

Peter Miskolczi's contributions to the field of pharmaceutical chemistry through his innovative patent and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic agents, showcasing the impact of dedicated professionals in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…